Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trial Imaging: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Clinical Trial Imaging estimated at US$931.2 Million in the year 2022, is projected to reach a revised size of US$1.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030.
Project & Data Management, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$472.8 Million by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Operational Imaging Services segment is readjusted to a revised 5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $253.7 Million, While China is Forecast to Grow at 9.2% CAGR
The Clinical Trial Imaging market in the U.S. is estimated at US$253.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$316.5 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$196 Million by the year 2030.
Select Competitors (Total 12 Featured) -
- Bioclinica, Inc.
- Biomedical Systems Corporation
- Biotelemetry, Inc.
- Cardiovascular Imaging Technologies, LLC
- ERT Clinical
- Icon PLC
- Image Core Lab
- Intrinsic Imaging LLC
- Ixico PLC
- Lyscaut Medical Imaging Company
- Medical Metrics
- Navitas Life Sciences
- Parexel International Corporation
- Perspectum Diagnostics
- Prism Clinical Imaging
- Quotient Sciences
- Radiant Sage LLC
- Resonance Health
- Worldcare Clinical, LLC
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Report Metrics:
| Report Attribute | Details |
| No. of Pages | 78 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $931.2 Million |
| Forecasted Market Value (USD) by 2030 | $1400 Million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Clinical Trial Imaging - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/7yggc4-trial?w=12
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
